Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity

Daniel H Kaplan1, Mathew C Jenison, Sem Saeland

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. dan.kaplan@yale.edu

Immunity
|December 17, 2005
PubMed

Insights

Epidermal Langerhans cells (LCs) are not essential for skin immunity and contact hypersensitivity (CHS). Their absence unexpectedly amplifies CHS, revealing a previously unknown regulatory role in immune responses.

Area of Science:

  • Immunology
  • Dermatology
  • Cell Biology

Background:

  • Epidermal Langerhans cells (LCs) are skin-resident dendritic cells crucial for initiating adaptive immunity.
  • Their precise role in skin immunity, particularly in contact hypersensitivity (CHS), remains incompletely understood.

Purpose of the Study:

  • To investigate the functional requirement of LCs in skin immunity.
  • To elucidate the role of LCs in the development of contact hypersensitivity.

Main Methods:

  • Generation of BAC transgenic mice with targeted ablation of epidermal LCs using diphtheria toxin.
  • Assessment of contact hypersensitivity responses in LCs-deficient mice.

Main Results:

  • Absence of epidermal LCs resulted in amplified, not abrogated, contact hypersensitivity responses.
  • LCs were found to regulate the priming phase of CHS, not the effector phase.
  • LCs demonstrated a previously unappreciated function in regulating immune responses.

Conclusions:

  • Epidermal LCs are dispensable for CHS.
  • LCs play a regulatory role in immune responses, specifically during the priming phase of CHS.
  • These findings challenge the established view of LCs' primary function in initiating adaptive immunity.